GB0326780D0 - Biological materials and uses thereof - Google Patents

Biological materials and uses thereof

Info

Publication number
GB0326780D0
GB0326780D0 GBGB0326780.4A GB0326780A GB0326780D0 GB 0326780 D0 GB0326780 D0 GB 0326780D0 GB 0326780 A GB0326780 A GB 0326780A GB 0326780 D0 GB0326780 D0 GB 0326780D0
Authority
GB
United Kingdom
Prior art keywords
biological materials
biological
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0326780.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0326780.4A priority Critical patent/GB0326780D0/en
Publication of GB0326780D0 publication Critical patent/GB0326780D0/en
Priority to AU2004292013A priority patent/AU2004292013A1/en
Priority to CA002546401A priority patent/CA2546401A1/fr
Priority to JP2006540577A priority patent/JP2007515162A/ja
Priority to CNA2004800406378A priority patent/CN1906491A/zh
Priority to EP04798515A priority patent/EP1718979A2/fr
Priority to PCT/GB2004/004795 priority patent/WO2005050203A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
GBGB0326780.4A 2003-11-18 2003-11-18 Biological materials and uses thereof Ceased GB0326780D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0326780.4A GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof
AU2004292013A AU2004292013A1 (en) 2003-11-18 2004-11-15 Methods for screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis
CA002546401A CA2546401A1 (fr) 2003-11-18 2004-11-15 Materiaux biologiques et utilisations correspondantes
JP2006540577A JP2007515162A (ja) 2003-11-18 2004-11-15 線維症の治療において使用する化合物の同定のためのｃｔｇｆ及びｔｒｋａレセプターを使用するスクリーニング方法
CNA2004800406378A CN1906491A (zh) 2003-11-18 2004-11-15 利用鉴定纤维样变性治疗中使用的化合物的ctgf和trka受体的筛选方法
EP04798515A EP1718979A2 (fr) 2003-11-18 2004-11-15 Methodes de criblage utilisant le ctgf et le recepteur trka pour l'identification de composes pour le traitement de la fibrose
PCT/GB2004/004795 WO2005050203A2 (fr) 2003-11-18 2004-11-15 Materiaux biologiques et utilisations correspondantes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0326780.4A GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof

Publications (1)

Publication Number Publication Date
GB0326780D0 true GB0326780D0 (en) 2003-12-24

Family

ID=29763971

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0326780.4A Ceased GB0326780D0 (en) 2003-11-18 2003-11-18 Biological materials and uses thereof

Country Status (7)

Country Link
EP (1) EP1718979A2 (fr)
JP (1) JP2007515162A (fr)
CN (1) CN1906491A (fr)
AU (1) AU2004292013A1 (fr)
CA (1) CA2546401A1 (fr)
GB (1) GB0326780D0 (fr)
WO (1) WO2005050203A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326778D0 (en) * 2003-11-18 2003-12-24 Imp College Innovations Ltd Biological materials and uses thereof
US20060275797A1 (en) * 2005-03-21 2006-12-07 Alcon Manufacturing, Ltd. Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
US8946172B2 (en) 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
US8252762B2 (en) 2008-08-25 2012-08-28 Excaliard Pharmaceuticals, Inc. Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
EP2169059A1 (fr) * 2008-09-25 2010-03-31 Academisch Medisch Centrum bij de Universiteit van Amsterdam Supports et procédés de compensation, prévention et/ou détermination de fibrose ou risque de fibrose
EP2221387A1 (fr) 2009-02-19 2010-08-25 Université de la Méditerranée Gène de sensibilité à la fibrose et ses utilisations
JP6177692B2 (ja) 2011-02-02 2017-08-09 エクスカリアード・ファーマシューティカルズ，インク 結合組織増殖因子（ｃｔｇｆ）をターゲティングするアンチセンス化合物を用いた、ケロイドまたは肥厚性瘢痕の治療法
CN104302780B (zh) 2011-08-05 2017-04-12 艾克斯-马赛大学 纤维变性易感性il22ra2基因及其用途
KR101467109B1 (ko) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Ｂｉｘ02189 화합물을 유효성분으로 포함하는 폐섬유증 예방 또는 치료용 조성물
KR101723997B1 (ko) 2014-02-05 2017-04-06 브이엠 온콜로지 엘엘씨 화합물의 조성물 및 이의 용도
JP2022533855A (ja) * 2019-05-30 2022-07-26 サンシャイン・レイク・ファーマ・カンパニー・リミテッド 抗ＴｒｋＡ抗体及びその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555322B1 (en) * 1999-08-27 2003-04-29 Fibrogen, Inc. α2-macroglobulin receptor as a receptor for CTGF

Also Published As

Publication number Publication date
CN1906491A (zh) 2007-01-31
EP1718979A2 (fr) 2006-11-08
AU2004292013A1 (en) 2005-06-02
JP2007515162A (ja) 2007-06-14
WO2005050203A2 (fr) 2005-06-02
CA2546401A1 (fr) 2005-06-02
WO2005050203A3 (fr) 2005-11-17

Similar Documents

Publication Publication Date Title
ZA200804864B (en) Biological materials and uses thereof
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
AU2003284875A8 (en) Biological scaffolding material
EP1699485A4 (fr) Anticorps anti-hydroxylase et utilisations
IL172510A0 (en) Antibodies and uses thereof
GB0519398D0 (en) Biological materials and uses thereof
GB0326780D0 (en) Biological materials and uses thereof
AP2127A (en) Multi-carbide material manufacture and use
EP1589033A4 (fr) Anticorps et utilisation de ce dernier
HK1094531A1 (en) P185neu-encoding dna and therapeutical uses thereof
GB0326778D0 (en) Biological materials and uses thereof
GB2400659B8 (en) Assay methods and materials
GB0318546D0 (en) Quinoxalinones and their use
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0321746D0 (en) Biological materials and uses thereof
GB0318063D0 (en) Biological material and uses thereof
GB0309203D0 (en) Biological material and uses thereof
EP1627888A4 (fr) Anticorps et son utilisation
EP1602666A4 (fr) Nouvelle proteine et son adn
GB0519397D0 (en) Biological materials and uses thereof
EP1531179A1 (fr) Nouvelles entités biologiques et leur utilisation
GB0321300D0 (en) Protein structure and uses thereof
GB0211496D0 (en) Disposable materials and articles

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)